These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 26092515)
1. Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials. Kasper S Wien Med Wochenschr; 2015 Jun; 165(11-12):217-28. PubMed ID: 26092515 [TBL] [Abstract][Full Text] [Related]
2. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Woelk H; Schläfke S Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials. Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Dienel A; Schläfke S Wien Med Wochenschr; 2010 Dec; 160(21-22):547-56. PubMed ID: 21170695 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials. Möller HJ; Volz HP; Dienel A; Schläfke S; Kasper S Eur Arch Psychiatry Clin Neurosci; 2019 Mar; 269(2):183-193. PubMed ID: 29150713 [TBL] [Abstract][Full Text] [Related]
5. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial. Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Dienel A; Schläfke S Int Clin Psychopharmacol; 2010 Sep; 25(5):277-87. PubMed ID: 20512042 [TBL] [Abstract][Full Text] [Related]
6. An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review. Kasper S Int J Psychiatry Clin Pract; 2013 Nov; 17 Suppl 1():15-22. PubMed ID: 23808618 [TBL] [Abstract][Full Text] [Related]
7. Effects of Ginkgo biloba extract EGb 761 ® in dementia with neuropsychiatric features: review of recently completed randomised, controlled trials. Ihl R Int J Psychiatry Clin Pract; 2013 Nov; 17 Suppl 1():8-14. PubMed ID: 23808613 [TBL] [Abstract][Full Text] [Related]
8. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. Woelk H; Arnoldt KH; Kieser M; Hoerr R J Psychiatr Res; 2007 Sep; 41(6):472-80. PubMed ID: 16808927 [TBL] [Abstract][Full Text] [Related]
9. Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine. Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Schläfke S; Dienel A Int J Neuropsychopharmacol; 2014 Jun; 17(6):859-69. PubMed ID: 24456909 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Napryeyenko O; Sonnik G; Tartakovsky I J Neurol Sci; 2009 Aug; 283(1-2):224-9. PubMed ID: 19286192 [TBL] [Abstract][Full Text] [Related]
11. Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set. Kasper S; Möller HJ; Volz HP; Schläfke S; Dienel A Int Clin Psychopharmacol; 2017 Jul; 32(4):195-204. PubMed ID: 28379882 [TBL] [Abstract][Full Text] [Related]
12. Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials. Trautmann-Sponsel RD; Dienel A J Affect Disord; 2004 Oct; 82(2):303-7. PubMed ID: 15488262 [TBL] [Abstract][Full Text] [Related]
13. Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials. Dold M; Möller HJ; Volz HP; Seifritz E; Schläfke S; Bartova L; Kasper S Eur Psychiatry; 2024 Mar; 67(1):e23. PubMed ID: 38425206 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep--A randomized, placebo-controlled trial. Kasper S; Anghelescu I; Dienel A Eur Neuropsychopharmacol; 2015 Nov; 25(11):1960-7. PubMed ID: 26293583 [TBL] [Abstract][Full Text] [Related]
15. Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial. Scripnikov A; Khomenko A; Napryeyenko O; Wien Med Wochenschr; 2007; 157(13-14):295-300. PubMed ID: 17704975 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Silexan in mixed anxiety-depression--A randomized, placebo-controlled trial. Kasper S; Volz HP; Dienel A; Schläfke S Eur Neuropsychopharmacol; 2016 Feb; 26(2):331-340. PubMed ID: 26718792 [TBL] [Abstract][Full Text] [Related]
17. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial. Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635 [TBL] [Abstract][Full Text] [Related]
18. Silexan in anxiety disorders: Clinical data and pharmacological background. Kasper S; Müller WE; Volz HP; Möller HJ; Koch E; Dienel A World J Biol Psychiatry; 2018 Sep; 19(6):412-420. PubMed ID: 28511598 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial. Ihl R; Tribanek M; Bachinskaya N; Pharmacopsychiatry; 2012 Mar; 45(2):41-6. PubMed ID: 22086747 [TBL] [Abstract][Full Text] [Related]
20. Conflicting results on ginkgo research. Le Bars P Forsch Komplementarmed Klass Naturheilkd; 2002 Feb; 9(1):19-20. PubMed ID: 11968151 [No Abstract] [Full Text] [Related] [Next] [New Search]